KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Work In Process (2016 - 2025)

Historic Work In Process for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $961.0 million.

  • Abbott Laboratories' Work In Process rose 957.81% to $961.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $961.0 million, marking a year-over-year increase of 957.81%. This contributed to the annual value of $840.0 million for FY2024, which is 408.92% up from last year.
  • Abbott Laboratories' Work In Process amounted to $961.0 million in Q3 2025, which was up 957.81% from $962.0 million recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Work In Process registered a high of $962.0 million during Q2 2025, and its lowest value of $680.0 million during Q4 2022.
  • Over the past 5 years, Abbott Laboratories' median Work In Process value was $807.0 million (recorded in 2023), while the average stood at $811.6 million.
  • Per our database at Business Quant, Abbott Laboratories' Work In Process soared by 2569.11% in 2021 and then crashed by 1080.4% in 2022.
  • Abbott Laboratories' Work In Process (Quarter) stood at $694.0 million in 2021, then fell by 2.02% to $680.0 million in 2022, then grew by 18.68% to $807.0 million in 2023, then increased by 4.09% to $840.0 million in 2024, then grew by 14.4% to $961.0 million in 2025.
  • Its Work In Process stands at $961.0 million for Q3 2025, versus $962.0 million for Q2 2025 and $890.0 million for Q1 2025.